IL126511A - Method for establishing a risk of developing disorders associated with g-protein dysregulation - Google Patents

Method for establishing a risk of developing disorders associated with g-protein dysregulation

Info

Publication number
IL126511A
IL126511A IL12651197A IL12651197A IL126511A IL 126511 A IL126511 A IL 126511A IL 12651197 A IL12651197 A IL 12651197A IL 12651197 A IL12651197 A IL 12651197A IL 126511 A IL126511 A IL 126511A
Authority
IL
Israel
Prior art keywords
establishing
risk
disorders associated
protein
protein dysregulation
Prior art date
Application number
IL12651197A
Other languages
English (en)
Other versions
IL126511A0 (en
Original Assignee
Winfried Siffert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Winfried Siffert filed Critical Winfried Siffert
Publication of IL126511A0 publication Critical patent/IL126511A0/xx
Publication of IL126511A publication Critical patent/IL126511A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL12651197A 1996-05-14 1997-05-02 Method for establishing a risk of developing disorders associated with g-protein dysregulation IL126511A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19619362A DE19619362A1 (de) 1996-05-14 1996-05-14 Verwendung einer Genveränderung im Gen für humanes G-Protein beta-3-Untereinheit zur Diagnostik von Erkrankungen
PCT/EP1997/002250 WO1997043442A1 (de) 1996-05-14 1997-05-02 VERWENDUNG EINER GENVERÄNDERUNG IM GEN FÜR DIE HUMANE G-PROTEIN β3-UNTEREINHEIT ZUR DIAGNOSTIK VON ERKRANKUNGEN

Publications (2)

Publication Number Publication Date
IL126511A0 IL126511A0 (en) 1999-08-17
IL126511A true IL126511A (en) 2003-11-23

Family

ID=7794252

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12651197A IL126511A (en) 1996-05-14 1997-05-02 Method for establishing a risk of developing disorders associated with g-protein dysregulation

Country Status (23)

Country Link
US (2) US6242181B1 (cs)
EP (1) EP0939833B1 (cs)
JP (1) JP2000509990A (cs)
KR (1) KR20000010988A (cs)
CN (1) CN1218515A (cs)
AT (1) ATE212066T1 (cs)
AU (1) AU732535B2 (cs)
BG (1) BG63214B1 (cs)
BR (1) BR9709245A (cs)
CA (1) CA2252921C (cs)
CZ (1) CZ292691B6 (cs)
DE (2) DE19619362A1 (cs)
EA (1) EA199800959A1 (cs)
HU (1) HUP9903661A3 (cs)
IL (1) IL126511A (cs)
NO (1) NO985280L (cs)
NZ (1) NZ332279A (cs)
PL (1) PL185779B1 (cs)
SK (1) SK282675B6 (cs)
TR (1) TR199802300T2 (cs)
UA (1) UA56164C2 (cs)
WO (1) WO1997043442A1 (cs)
ZA (1) ZA974102B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19637518A1 (de) * 1996-09-13 1998-04-09 Winfried Siffert PTX-sensitive G-Proteine, ihre Herstellung und Verwendung
US6653073B1 (en) * 1998-02-20 2003-11-25 City Of Hope Association of the serotonin transport (HTT) gene with cardiovascular disease and longevity
AU6079999A (en) * 1998-09-10 2000-04-03 Winfried Siffert Gene modification in the gene for the die gbeta3-sub-unit of human g-protein
WO2001057246A1 (de) * 2000-02-03 2001-08-09 Winfried Siffert VERWENDUNG EINER GENVERÄNDERUNG IM GEN FÜR DIE β3-UNTEREINHEIT DES HUMANEN G-PROTEINS
JP4140329B2 (ja) 2002-09-25 2008-08-27 財団法人名古屋産業科学研究所 高血圧のリスク診断方法
EP2463384A3 (en) 2010-12-07 2013-03-13 Medtronic, Inc. Diagnostic kits, genetic markers and methods for SCD or SCA therapy selection
WO2019191010A1 (en) * 2018-03-27 2019-10-03 Aardvark Therapeutics Inc. Personalized treatment method for congestive heart failure

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19637518A1 (de) * 1996-09-13 1998-04-09 Winfried Siffert PTX-sensitive G-Proteine, ihre Herstellung und Verwendung
AU6079999A (en) * 1998-09-10 2000-04-03 Winfried Siffert Gene modification in the gene for the die gbeta3-sub-unit of human g-protein

Also Published As

Publication number Publication date
EP0939833B1 (de) 2002-01-16
US6242181B1 (en) 2001-06-05
EP0939833A1 (de) 1999-09-08
DE19619362A1 (de) 1997-11-20
BG102878A (en) 1999-05-31
CA2252921A1 (en) 1997-11-20
WO1997043442A1 (de) 1997-11-20
AU2890297A (en) 1997-12-05
CA2252921C (en) 2008-07-08
PL330014A1 (en) 1999-04-26
KR20000010988A (ko) 2000-02-25
CZ292691B6 (cs) 2003-11-12
ZA974102B (en) 1998-11-13
DE59706027D1 (de) 2002-02-21
EA199800959A1 (ru) 1999-06-24
AU732535B2 (en) 2001-04-26
ATE212066T1 (de) 2002-02-15
BR9709245A (pt) 1999-08-10
SK282675B6 (sk) 2002-11-06
HUP9903661A3 (en) 2000-09-28
JP2000509990A (ja) 2000-08-08
CZ369698A3 (cs) 1999-08-11
NZ332279A (en) 2000-04-28
HUP9903661A2 (hu) 2000-03-28
IL126511A0 (en) 1999-08-17
PL185779B1 (pl) 2003-07-31
UA56164C2 (uk) 2003-05-15
CN1218515A (zh) 1999-06-02
BG63214B1 (bg) 2001-06-29
NO985280D0 (no) 1998-11-12
NO985280L (no) 1998-11-12
TR199802300T2 (xx) 1999-02-22
SK157398A3 (en) 2000-01-18
US20020142311A1 (en) 2002-10-03

Similar Documents

Publication Publication Date Title
CA2158750A1 (en) Monoclonal antibodies to casein kinase i polypeptides
WO1999024463A3 (en) Signal peptide-containing proteins
WO1998058052A3 (en) Disease associated protein kinases
EP1690939B8 (en) Novel G protein-coupled receptor proteins
AU6982500A (en) Fv antibody construct comprising binding sites for a cd16 receptor and a cd30 surface protein
IL126511A (en) Method for establishing a risk of developing disorders associated with g-protein dysregulation
WO1999024587A3 (en) Human phospholipase a2 protein and dna encoding it
WO1999033981A3 (en) Human signal peptide-containing proteins
MXPA02000293A (es) Isoformas de la amp ciclico fosfodiesterasa y metodos de uso.
WO1999009182A3 (en) Rab proteins
EP0781848A3 (en) Fused DNA sequence, fused protein expressed from said fused DNA sequence and method for expressing said fused protein
WO2000065054A3 (en) Human membrane-associated proteins
WO1998059041A3 (en) Disease related nucleotide kinases
WO1999021994A3 (en) Human vesicle membrane protein-like proteins
EP0811695A3 (en) Mutant S182(PS-1) genes
WO1998057986A3 (en) Human preprotachykinin b
WO1999000408A3 (en) Human transmembrane protein from the transmembrane 4 superfamily
WO1999041375A3 (en) Human receptor proteins
DE59914061D1 (de) Das gen prv-1 und dessen verwendung
WO1998041538A3 (en) Novel human cytokine/steroid receptor protein
WO2000026243A3 (en) Transmembrane 4 proteins
FI973762A0 (fi) Ny gen
WO2001048240A3 (en) Implication of a known gene named cp2/lsf-lbp-1 in alzheimer's desease
WO1999064596A3 (en) Proteins regulating gene expression
WO2000014248A8 (en) Cyclic nucleotide-associated proteins

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees